Onkos Surgical

Onkos Surgical is a precision orthopedic implant and surgical solutions company specializing in patient-matched, personalized approaches to complex bone and soft tissue reconstruction. The company serves over 350 leading academic medical institutions across the United States, focusing on oncologic and complex orthopedic cases including limb salvage, tumor reconstruction, and joint preservation. Onkos' core offerings include the ELEOS™ Limb Salvage System featuring BioGrip® Technology—a 3D-printed implant design addressing soft tissue and implant loosening failures—and the My3D® Personalized Solutions platform, a digital patient-matched system providing pre-operative planning, 3D visualization, graft-matching services, and comprehensive instrumentation. The company also manufactures the JTS (Juvenile Tumor System), an extendible implant for pediatric bone tumor patients that lengthens as the child grows. A key innovation is NanoCept®, the first FDA-granted antibacterial coating technology for orthopedic implants, demonstrated to protect implants from bacterial contamination at the time of surgery prior to implantation. The company emphasizes surgeon-driven, patient-inspired design reducing surgical complexity while driving personalization and addressing clinical challenges. Onkos combines virtual surgical planning, 3D modeling and printing, implant design, and workflow optimization to support improved patient outcomes. The company is actively engaged in post-market surveillance studies and has opened a dedicated Innovation Center for NanoCept® antibacterial technology development and manufacturing.